(Q50936265)

25 March 2018

title

A randomized double blind placebo controlled multicenter study of mesalazine for the prevention of acute radiation enteritis. (English)

1 reference

25 March 2018

1 reference

Resbeut M

1

1 reference

25 March 2018

Marteau P

2

1 reference

25 March 2018

Cowen D

3

1 reference

25 March 2018

Richaud P

4

1 reference

25 March 2018

Bourdin S

5

1 reference

25 March 2018

Dubois JB

6

1 reference

25 March 2018

Mere P

7

1 reference

25 March 2018

N'Guyen TD

8

1 reference

25 March 2018

publication date

1 July 1997

1 reference

25 March 2018

Radiotherapy and Oncology

published in

1 reference

25 March 2018

volume

44

1 reference

25 March 2018

issue

1

1 reference

25 March 2018

page(s)

59-63

1 reference

25 March 2018

Clinical evidence supporting the radical scavenger mechanism of 5-aminosalicylic acid

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900064-9

7 January 2021

A randomized trial to assess the efficacy of 5-aminosalicylic acid for the prevention of radiation enteritis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900064-9

7 January 2021

The relationship between early and late gastrointestinal complications of radiation therapy for carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900064-9

7 January 2021

A prospective study of treatment techniques to minimize the volume of pelvic small bowel with reduction of acute and late effects associated with pelvic irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900064-9

7 January 2021

Review article: the mode of action of the aminosalicylates in inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900064-9

7 January 2021

Overall treatment time in advanced cervical carcinomas: a critical parameter in treatment outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900064-9

7 January 2021

Decreasing gastrointestinal morbidity with the use of small bowel contrast during treatment planning for pelvic irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900064-9

7 January 2021

Delivery and fate of oral mesalamine microgranules within the human small intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900064-9

7 January 2021

Adverse events in patients treated with 5-aminosalicyclic acid: 1993-1994 pharmacovigilance report for Pentasa in France

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900064-9

7 January 2021

Olsalazine is contraindicated during pelvic radiation therapy: results of a double-blind, randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900064-9

7 January 2021

The effect of indomethacin on acute radiation induced gastrointestinal injury: a morphologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900064-9

7 January 2021

Preservation of intestinal integrity during radiotherapy using live Lactobacillus acidophilus cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900064-9

7 January 2021

Effect of azodisal sodium and sulphasalazine on ileostomy output of fluid and PGE2 and PGF2 alpha in subjects with a permanent ileostomy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900064-9

7 January 2021

Olsalazine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2897%2900064-9

7 January 2021

10.1016/S0167-8140(97)00064-9

Identifiers

DOI

1 reference

25 March 2018

PubMed ID

9288859

1 reference

25 March 2018